Literature DB >> 29897849

Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.

Vivek Shinde1, Louis Fries1, Yukun Wu1, Sapeckshita Agrawal1, Iksung Cho1, D Nigel Thomas1, Michelle Spindler1, Elizabeth Lindner1, Timothy Hahn1, Joyce Plested1, David Flyer1, Michael J Massare1, Bin Zhou1, Amy Fix1, Gale Smith1, Gregory M Glenn1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29897849     DOI： 10.1056/NEJMc1803554

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

Review 2.  Advances in Infectious Disease Vaccine Adjuvants.

Authors:  Jingyi Fan; Shengbin Jin; Lachlan Gilmartin; Istvan Toth; Waleed M Hussein; Rachel J Stephenson
Journal:  Vaccines (Basel)       Date:  2022-07-13

Review 3.  Aging and Options to Halt Declining Immunity to Virus Infections.

Authors:  Miguel Ángel Palacios-Pedrero; Albert D M E Osterhaus; Tanja Becker; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

4.  Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens.

Authors:  Joseph J Illingworth; Daniel G Alanine; Rebecca Brown; Jennifer M Marshall; Helen E Bartlett; Sarah E Silk; Geneviève M Labbé; Doris Quinkert; Jee Sun Cho; Jason P Wendler; David J Pattinson; Lea Barfod; Alexander D Douglas; Michael W Shea; Katherine E Wright; Simone C de Cassan; Matthew K Higgins; Simon J Draper
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 5.  Better influenza vaccines: an industry perspective.

Authors:  Juine-Ruey Chen; Yo-Min Liu; Yung-Chieh Tseng; Che Ma
Journal:  J Biomed Sci       Date:  2020-02-14       Impact factor: 8.410

6.  A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine.

Authors:  Susheel K Singh; Jordan Plieskatt; Bishwanath K Chourasia; Amanda Fabra-García; Asier Garcia-Senosiain; Vandana Singh; Karin Lövgren Bengtsson; Jenny M Reimer; Robert Sauerwein; Matthijs M Jore; Michael Theisen
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

7.  Nanocarrier vaccines for SARS-CoV-2.

Authors:  Jatin Machhi; Farah Shahjin; Srijanee Das; Milankumar Patel; Mai Mohamed Abdelmoaty; Jacob D Cohen; Preet Amol Singh; Ashish Baldi; Neha Bajwa; Raj Kumar; Lalit K Vora; Tapan A Patel; Maxim D Oleynikov; Dhruvkumar Soni; Pravin Yeapuri; Insiya Mukadam; Rajashree Chakraborty; Caroline G Saksena; Jonathan Herskovitz; Mahmudul Hasan; David Oupicky; Suvarthi Das; Ryan F Donnelly; Kenneth S Hettie; Linda Chang; Howard E Gendelman; Bhavesh D Kevadiya
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 17.873

8.  SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.

Authors:  Jing-Hui Tian; Nita Patel; Robert Haupt; Haixia Zhou; Stuart Weston; Holly Hammond; James Logue; Alyse D Portnoff; James Norton; Mimi Guebre-Xabier; Bin Zhou; Kelsey Jacobson; Sonia Maciejewski; Rafia Khatoon; Malgorzata Wisniewska; Will Moffitt; Stefanie Kluepfel-Stahl; Betty Ekechukwu; James Papin; Sarathi Boddapati; C Jason Wong; Pedro A Piedra; Matthew B Frieman; Michael J Massare; Louis Fries; Karin Lövgren Bengtsson; Linda Stertman; Larry Ellingsworth; Gregory Glenn; Gale Smith
Journal:  Nat Commun       Date:  2021-01-14       Impact factor: 14.919

9.  Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.

Authors:  Neil Formica; Raburn Mallory; Gary Albert; Michelle Robinson; Joyce S Plested; Iksung Cho; Andreana Robertson; Filip Dubovsky; Gregory M Glenn
Journal:  PLoS Med       Date:  2021-10-01       Impact factor: 11.069

10.  Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.

Authors:  Sandhya Bangaru; Gabriel Ozorowski; Hannah L Turner; Aleksandar Antanasijevic; Deli Huang; Xiaoning Wang; Jonathan L Torres; Jolene K Diedrich; Jing-Hui Tian; Alyse D Portnoff; Nita Patel; Michael J Massare; John R Yates; David Nemazee; James C Paulson; Greg Glenn; Gale Smith; Andrew B Ward
Journal:  bioRxiv       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.